For two years, markets’ belief that the rise of artificial intelligence would usher in a new era of productivity growth has fueled trillions of dollars in stock-market gains.

It wants to crush (forget 'turn back") the clock on diversity and inclusion in America. Fighting bac requires looking back - and getting it right this time.

The new trading year is getting started, and investors might be looking to make this one either as strong as 2024 was or even ...

We recently compiled a list of the 10 Firms Post Impressive Gains on Monday. In this article, we are going to take a look at ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...

As a progressive freshman mayor, Johnson’s challenge now is to stand up for Chicago’s large immigrant community while also navigating the risks of antagonizing Trump.

Analysts discuss Johnson & Johnson's outlook, highlighting MedTech challenges, litigation risks, pipeline opportunities, and mixed performance across segments.

Johnson & Johnson (JNJ – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Lee ...

J&J’s 2025 results will be the launching point for its guidance of 5%-7% revenue growth for 2025-30, which is still well ...

Project Stargate will see companies like Oracle, SoftBank, MGX, and OpenAI commit an initial $100 billion to build data ...

We recently compiled a list of the 13 Highest Yielding Dividend Stocks in the Dow. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against the other high ...

The Wall Street Journal editorial board tore into President Donald Trump for pardoning the rioters who attacked the Capitol ...